Interferon-β gene transfer inhibits melanoma cells adhesion and migration

Cytokine

Volumn 89, Issue , 2017, Pages 201-208

  Rossi, U A ^a   Finocchiaro, Liliana M E ^a   Glikin, Gerardo C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Canine; DMRIE; Human; Lipofection; ROS; Spheroids

Indexed keywords

CATALASE; GELATIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT BETA INTERFERON; SCLEROPROTEIN; BETA INTERFERON; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CELL ADHESION; CONTROLLED STUDY; CULTURE MEDIUM; DOG; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; INTERFERON BETA GENE; MELANOMA CELL; MIGRATION INHIBITION; MONOLAYER CULTURE; MULTICELLULAR SPHEROID; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; ANIMAL; CELL MOTION; GENETICS; IMMUNOLOGY; MELANOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOGS; GENE TRANSFER TECHNIQUES; HUMANS; INTERFERON-BETA; MELANOMA; NEOPLASM PROTEINS; SPHEROIDS, CELLULAR;

EID: 84964922337     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.11.012     Document Type: Article

References (45)

1. [1] Siegel, R., Miller, K., Jemal, A., Cancer statistics. CA Cancer J. Clin. 65 (2015), 5–29.
2. [2] Tarhini, A.A., Agarwala, S.S., Cutaneous melanoma: available therapy for metastatic disease. Dermatol. Ther. 19 (2006), 19–25.
3. [3] Chin, L., Garraway, L.A., Fisher, D.E., Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 20 (2006), 2149–2182.
4. [4] Ramos-Vara, J.A., Beissenherz, M.E., Miller, M.A., Johnson, G.C., Pace, L.W., et al. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet. Pathol. 37 (2000), 597–608.
5. [5] Modiano, J.F., Breen, M., Lana, S.L., Ehrhart, N., Fosmire, S.P., et al. Naturally occurring translational models for development of cancer gene therapy. Gene Ther. Mol. Biol. 10 (2006), 31–40.
6. [6] Simpson, R.M., Bastian, B.C., Michael, H.T., Webster, J.D., Prasad, M.L., et al. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigm. Cell Melanoma Res. 27 (2014), 37–47.
7. [7] Jiao, Y., Feng, X., Zhan, Y., Wang, R., Zheng, S., et al. Matrix metalloproteinase-2 promotes αvβ3 integrin-mediated adhesion and migration of human melanoma cells by cleaving fibronectin. PLoS One, 7, 2012, e41591.
8. [8] Leber, M.F., Efferth, T., Molecular principles of cancer invasion and metastasis. Int. J. Oncol. 34 (2009), 881–895.
9. [9] Eccles, S., Box, C., Court, W., Cell migration/invasion assays and their application in cancer drug discovery. Biotechnol. Annu. Rev. 11 (2005), 391–421.
10. [10] Friedrich, J., Ebner, R., Kunz-Schughart, L.A., Experimental anti-tumor therapy in 3-D: spheroids–old hat or new challenge?. Int. J. Radiat. Biol. 83 (2007), 849–871.
11. [11] Santini, M., Rainaldi, G., Indovina, P., Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit. Rev. Oncol. Hematol. 36 (2000), 75–87.
12. [12] Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol., 10, 2012, 29.
13. [13] Ismail, A., Yusuf, N., Type I interferons: key players in normal skin and select cutaneous malignancies. Dermatol. Res. Pract., 2014, 2014, 847545.
14. [14] Kirkwood, J.M., Ibrahim, J.G., Sondak, V.K., Richards, J., Flaherty, L.E., et al. High- and low dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J. Clin. Oncol. 18 (2000), 2444–2458.
15. [15] Johns, T., Mackay, I., Callister, K., Hertzog, P., Devenish, R., et al. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. J. Natl Cancer Inst. 84 (1992), 1185–1190.
16. [16] Ambjørn, M., Ejlerskov, P., Liu, Y., Lees, M., Jäättelä, M., et al. IFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function. Autophagy 9 (2013), 287–302.
17. [17] Benedict, W.F., Tao, Z., Kim, C.S., Zhang, X., Zhou, J.H., et al. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein. Mol. Ther. 10 (2004), 525–532.
18. [18] Prat, A., Biernacki, K., Antel, J.P., Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. J. Autoimmun. 24 (2005), 119–124.
19. [19] Yen, J.H., Kong, W., Ganea, D., IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J. Immunol. 184 (2010), 3478–3486.
20. [20] Stuve, O., Chabot, S., Jung, S.S., Williams, G., Yong, V.W., Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J. Neuroimmunol. 80 (1997), 38–46.
21. [21] Cheng, X., Liu, Y., Chu, H., Kao, H.Y., Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα). J. Biol. Chem. 287 (2012), 23356–23367.
22. [22] Kondo, H., Yonezawa, Y., Ito, H., Interferon-beta, an autocrine cytokine, suppresses human fetal skin fibroblast migration into a denuded area in a cell monolayer but is not involved in the age related decline of cell migration. Mech. Ageing Dev. 87 (1996), 141–153.
23. [23] Rossi, U.A., Gil-Cardeza, M.L., Villaverde, M.S., Finocchiaro, L.M., Glikin, G.C., Interferon-β gene transfer induces a strong cytotoxic bystander effect on melanoma cells. Biomed. Pharmacother. 72 (2015), 44–51.
24. [24] López, M.V., Viale, D.L., Cafferata, E.G., Bravo, A.L., Carbone, C., et al. Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses. PLoS One, 4, 2009, e5119.
25. [25] Finocchiaro, L.M., Bumaschny, V.F., Karara, A.L., Fiszman, G.L., Casais, C.C., et al. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids. Cancer Gene Ther. 11 (2004), 333–345.
26. [26] Villaverde, M.S., Gil-Cardeza, M.L., Glikin, G.C., Finocchiaro, L.M., Interferon-β lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-β gene transfer to human tumor cells. Cancer Gene Ther. 19 (2012), 420–430.
27. [27] Finocchiaro, L.M., Villaverde, M.S., Gil-Cardeza, M.L., Riveros, M.D., Glikin, G.C., Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas. Res. Vet. Sci. 9 (2011), 230–234.
28. [28] Liang, C., Park, A., Guan, J., In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2 (2007), 329–333.
29. [29] Rørth, P., Collective cell migration. Annu. Rev. Cell Dev. Biol. 25 (2009), 407–429.
30. [30] Friedl, P., Hegerfeldt, Y., Tusch, M., Collective cell migration in morphogenesis and cancer. Int. J. Dev. Biol. 48 (2004), 441–449.
31. [31] Dangles, V., Lazar, V., Validire, P., Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. Br. J. Cancer 86 (2002), 1283–1289.
32. [32] Kidera, Y., Tsubaki, M., Yanae, M., Nishida, S., Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway. J. Exp. Clin. Cancer Res., 29, 2010, 127.
33. [33] Luanpitpong, S., Talbott, S.J., Rojanasakul, Y., Nimmannit, U., Pongrakhananon, V., et al. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J. Biol. Chem. 285 (2010), 38832–38840.
34. [34] Payne, S., Fogelgren, B., Hess, A., Seftor, E., Wiley, E., et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 65 (2005), 11429–11436.
35. [35] Novo, E., Marra, F., Zamara, E., Valfrè di Bonzo, L., Caligiuri, A., et al. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut 55 (2006), 90–97.
36. 2+ uptake and reactive oxygen species generation. Cell Death Dis., 5, 2014, e1482.
37. [37] Polytarchou, C., Hatziapostolou, M., Papadimitriou, E., Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J. Biol. Chem. 280 (2005), 40428–40435.
38. [38] Gilli, F., Bertolotto, A., Sala, A., Hoffmann, F., Capobianco, M., et al. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs. Brain 127 (2004), 259–268.
39. [39] Purushoth, E., Karpagam, V., Shila, S., Sundaresan, S., Inhibitory effects of interferon β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation. Fundam. Clin. Pharmacol. 29 (2015), 278–285.
40. [40] Ethiraj, P., Veerappan, K., Doraisami, B., Sivapatham, S., Synergistic anti-carcinogenic effect of interferon-β with cisplatin on human breast adenocarcinoma MDA MB231 cells. Int. Immunopharmacol. 23 (2014), 222–228.
41. [41] Wick, W., Wagner, S., Kerkau, S., Dichgans, J., Tonn, J.C., et al. BCL-2 promotes migration and invasiveness of human glioma cells. FEBS Lett. 440 (1998), 419–424.
42. [42] Lai, K.C., Chang, K.W., Liu, C.J., Kao, S.Y., Lee, T.C., IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma. Mol. Cancer Res. 6 (2008), 1431–1439.
43. [43] Sutton, S., Koach, J., Tan, O., Liu, B., Carter, D., et al. TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells. Oncotarget 5 (2014), 10127–10139.
44. [44] Lykhova, A.A., Kudryavets, Y.I., StrokovskaI, L.I., Bezdenezhnykh, N.Y., Semesiuk, N.I., et al. Suppression of proliferation, tumorigenicity and metastasis of lung cancer cells after their transduction by interferon-beta gene in baculovirus vector. Cytokine 71 (2015), 318–326.
45. [45] Angelucci, C., Iacopino, F., Ferracuti, S., Urbano, R., Sica, G., Recombinant human IFN-beta affects androgen receptor level, neuroendocrine differentiation, cell adhesion, and motility in prostate cancer cells. J. Interferon Cytokine Res. 27 (2007), 643–652.